News 25 June, 2020 - 14:00 (CEST) M The below WHO Public Assessment Report (WHOPAR) for trastuzumab was published: BT-ON001 - Trastuzumab - 150mg - Powder for concentrate for solution for infusion - Samsung Bioepis NL B.V - The Netherlands